Ms. Hirano is our Senior Vice President, Regulatory Affairs and has over 20 years of regulatory affairs in the biopharmaceutical industry. She joined the Company as Vice President, Regulatory Affairs in January, 2019. From April, 2017 through December, 2018, Ms. Hirano served as Head of Regulatory Affairs and Quality at the Company in a consulting capacity.
Prior to this, she was an independent regulatory consultant since April, 2010, providing regulatory affairs, project management, and clinical operations expertise to biopharmaceutical and biosimilar companies. Her experience encompasses the development of pharmaceuticals, biologics, and drug-device combination products for the treatment of oncology, cardiovascular, neurology, pulmonary/allergy, and endocrine/metabolic diseases. Prior to 2010, she held various positions of increasing responsibility at the Company, Titan Pharmaceuticals, Inc., PRTM (now PWC), CV Therapeutics, Inc. (acquired by Gilead), and Matrix Pharmaceutical, Inc. (acquired by Chiron Corp). She has also been the coordinator of the Bay Area Compliance Discussion Group since 1998. She has been a Director at The Big C Society since April 2014. She earned a Bachelor's degree in physical education from the University of California, Berkeley, and Master of Public Health degree from San Jose State University.
What is Patricia C. Hirano's net worth?
The estimated net worth of Patricia C. Hirano is at least $695.69 thousand as of July 1st, 2025. Ms. Hirano owns 13,206 shares of Soleno Therapeutics stock worth more than $695,692 as of December 4th. This net worth estimate does not reflect any other assets that Ms. Hirano may own. Additionally, Ms. Hirano receives a salary of $493,000.00 as Insider at Soleno Therapeutics. Learn More about Patricia C. Hirano's net worth.
How old is Patricia C. Hirano?
Ms. Hirano is currently 58 years old. There are 5 older executives and no younger executives at Soleno Therapeutics. The oldest executive at Soleno Therapeutics is Mr. James H. MacKaness, Chief Financial Officer, who is 60 years old. Learn More on Patricia C. Hirano's age.
What is Patricia C. Hirano's salary?
As the Insider of Soleno Therapeutics, Inc., Ms. Hirano earns $493,000.00 per year. There are 2 executives that earn more than Ms. Hirano. The highest earning executive at Soleno Therapeutics is Dr. Anish Bhatnagar M.D., President, CEO, COO & Director, who commands a salary of $1,060,000.00 per year. Learn More on Patricia C. Hirano's salary.
How do I contact Patricia C. Hirano?
Has Patricia C. Hirano been buying or selling shares of Soleno Therapeutics?
Patricia C. Hirano has not been actively trading shares of Soleno Therapeutics over the course of the past ninety days. Most recently, Patricia C. Hirano sold 3,830 shares of the business's stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $82.76, for a transaction totalling $316,970.80. Following the completion of the sale, the insider now directly owns 13,206 shares of the company's stock, valued at $1,092,928.56. Learn More on Patricia C. Hirano's trading history.
Who are Soleno Therapeutics' active insiders?
Are insiders buying or selling shares of Soleno Therapeutics?
In the last twelve months, insiders at the sold shares 11 times. They sold a total of 964,128 shares worth more than $65,188,281.94. The most recent insider tranaction occured on July, 1st when insider Patricia C Hirano sold 3,830 shares worth more than $316,970.80. Insiders at Soleno Therapeutics own 6.4% of the company.
Learn More about insider trades at Soleno Therapeutics. Information on this page was last updated on 7/1/2025.
